Products

What will AGI do for Bevantolol?

This classification denotes a beta-adrenergic blocking agent with the molecular formula C20H27NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 34ZXW6ZV21, chemically known as 2-propanol, 1-((2-(3,4-dimethoxyphenyl)ethyl)amino)-3-(3-methylphenoxy)- but generally known as bevantolol, which bears US NIH Compound Identifier 2372. Bevantolol most often comes in base, hydrochloride, and metabolite forms. European Medicines Agency schedules Bevantolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05808MIG. The term BEVANTOLOL is an International Non-Proprietary Name. World Health Organization schedules bevantolol in its Anatomical Therapeutic Chemical (ATC) Classification. BEVANTOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bevantolol under HS 29225000 and SITC 51467. As of Q4 2014, BEVANTOLOL remains the US FDA Preferred Term for this commodity. Bevantolol bears US NLM identifiers UMLS ID C0053532 and NCI Concept Code C79556. SMILES: O(CC(O)CNCCC1CC(OC)C(OC)CC1)C1CC(CCC1)C.